awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47099597-19A40D61-09DF-4E97-8AC1-769D21C675BD
Q47099597-19A40D61-09DF-4E97-8AC1-769D21C675BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47099597-19A40D61-09DF-4E97-8AC1-769D21C675BD
Improving Access to Cancer Treatments: The Role of Biosimilars.
P2860
Q47099597-19A40D61-09DF-4E97-8AC1-769D21C675BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47099597-19A40D61-09DF-4E97-8AC1-769D21C675BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
784dbb419c865173feac752b5e4020726b486698
P2860
A phase III randomized equivalence study of biosimilar filgrastim versus Amgen filgrastim in patients receiving myelosuppressive chemotherapy for breast cancer.